 |
 |

Direct Medical Costs for Surgical and Medical Treatment of Condylomata Acuminata
Murad Alam, MD;
Matthew Stiller, MD
Arch Dermatol. 2001;137:337-341.
Objective To determine which treatment modalities for condylomata acuminata are associated with the lowest direct medical costs.
Design Cost-effectiveness analysis.
Setting Ambulatory private practice, primary or specialty care.
Patients or Other Participants Adults with no presenting complaints other than condylomata acuminata.
Interventions Construction of a cost-effectiveness model. From a literature review, extraction of commonly accepted guidelines regarding duration and frequency as well as reports of efficacies of typical treatment regimens; from Medicare physician fee schedules, costs of physician visits and physician-administered treatments; from published data, average wholesale prices of medications.
Main Outcome Measure Estimated direct medical costs per complete clearance associated with different treatment options for condylomata acuminata.
Results Mean direct medical costs per complete clearance are lowest for surgical excision ($285). Other low-cost modalities are loop electrosurgical excision procedure ($316), electrodesiccation ($347), carbon dioxide laser ($416), podofilox ($424), and pulsed-dye laser ($479). Higher-cost modalities are cryotherapy ($951), trichloroacetic acid ($986), imiquimod ($1255), podophyllum resin ($1632), and interferon alfa-2b ($6665).
Conclusion Surgical modalities, including excision, electrodesiccation, loop electrosurgical excision procedure, and laser, as well as podofilox are low-cost options for the treatment of condylomata acuminata.
From the Department of Dermatology, College of Physicians and Surgeons, Columbia University, New York, NY.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(3):393.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Reducing the Economic Burden of HPV-Related Diseases
Mayeaux
JAOA: Journal of the American Osteopathic Association 2008;108:S2-S7.
ABSTRACT
| FULL TEXT
Epidemiology and Natural History of Genital Human Papillomavirus Infection
Weaver
JAOA: Journal of the American Osteopathic Association 2006;106:S2-S8.
ABSTRACT
| FULL TEXT
Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts
Lacey et al.
Sex. Transm. Infect. 2003;79:270-275.
ABSTRACT
| FULL TEXT
Direct Medical Cost for Surgical and Medical Treatment of Condylomata Acuminata
Kuwahara et al.
Arch Dermatol 2002;138:533-534.
FULL TEXT
|